10/01/2026 | Press release | Distributed by Public on 10/01/2026 15:19
| FORM C |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL |
|
|
OMB Number: ####-#### Estimated average burden hours per response: ##.# |
| Filer CIK: |
0002004745
|
| Filer CCC: |
XXXXXXXX
|
| Period: |
12-31-2025
|
| Is this a LIVE or TEST Filing? | LIVE TEST |
| Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
| Would you like a Return Copy? |
| Name: |
|
| Phone Number: |
|
| Contact E-Mail Address: |
|
| Notify via Filing Website only? |
| Name of Issuer: |
Aether Therapeutics Inc.
|
| Form: |
Corporation
|
| Jurisdiction of Incorporation/Organization: |
DELAWARE
|
| Date of Incorporation/Organization: |
12-19-2017
|
| Address 1: |
4200 MARATHON BLVD
|
| Address 2: |
STE 200
|
| City: |
AUSTIN
|
| State/Country: |
TEXAS
|
| Mailing Zip/Postal Code: |
78756
|
| Website of Issuer: |
http://www.aethertherapeutics.com/
|
| Current Number of Employees: |
2.00
|
| Total Assets Most Recent Fiscal Year-end: |
75756.21
|
| Total Assets Prior Fiscal Year-end: |
9609.77
|
| Cash and Cash Equivalents Most Recent Fiscal Year-end: |
63792.22
|
| Cash and Cash Equivalents Prior Fiscal Year-end: |
9067.12
|
| Accounts Receivable Most Recent Fiscal Year-end: |
0.00
|
| Accounts Receivable Prior Fiscal Year-end: |
0.00
|
| Short-term Debt Most Recent Fiscal Year-end: |
404976.98
|
| Short-term Debt Prior Fiscal Year-end: |
0.00
|
| Long-term Debt Most Recent Fiscal Year-end: |
0.00
|
| Long-term Debt Prior Fiscal Year-end: |
115000.00
|
| Revenue/Sales Most Recent Fiscal Year-end: |
0.00
|
| Revenue/Sales Prior Fiscal Year-end: |
0.00
|
| Cost of Goods Sold Most Recent Fiscal Year-end: |
0.00
|
| Cost of Goods Sold Prior Fiscal Year-end: |
0.00
|
| Taxes Paid Most Recent Fiscal Year-end: |
0.00
|
| Taxes Paid Prior Fiscal Year-end: |
0.00
|
| Net Income Most Recent Fiscal Year-end: |
-580436.20
|
| Net Income Prior Fiscal Year-end: |
-1070791.24
|
| Issuer: |
Aether Therapeutics Inc.
|
| Signature: |
Enter these top to bottom, matching the signed authorization. Issuer: Keep Aether Therapeutics Inc. Signature: Aaron Schuchart
|
| Title: |
Principal Executive Officer
|
| Signature: |
Aaron Schuchart
|
| Title: |
Principal Executive Officer
|
| Date: |
08-03-2026
|
| Signature: |
Aaron Schuchart
|
| Title: |
Principal Financial Officer
|
| Date: |
08-03-2026
|
| Signature: |
Aaron Schuchart
|
| Title: |
Controller or Principal Accounting Officer
|
| Date: |
08-03-2026
|
| Signature: |
Richard Hawkins
|
| Title: |
Board Member
|
| Date: |
08-03-2026
|
| Signature: |
Jon Saxe
|
| Title: |
Board Member
|
| Date: |
08-03-2026
|
| Signature: |
John Harris
|
| Title: |
Board Member
|
| Date: |
08-03-2026
|
| Signature: |
Wolfgang Sadee
|
| Title: |
Board Member
|
| Date: |
08-03-2026
|